首页> 外文期刊>ANZ journal of surgery >Outcomes of endoscopic retrograde cholangiopancreatography: a series from a provincial New Zealand hospital
【24h】

Outcomes of endoscopic retrograde cholangiopancreatography: a series from a provincial New Zealand hospital

机译:内窥镜逆行胆管胰岛素的结果:来自省新西兰医院的一系列

获取原文
获取原文并翻译 | 示例

摘要

Background Endoscopic retrograde cholangiopancreatography ( ERCP ) is an essential tool in the management of pancreaticobiliary pathology. It is technically demanding and has the potential to cause significant morbidity and mortality. Several trials have identified small centres and lower hospital volume as risk factors for lower success rates and higher complication rates. Taranaki Base Hospital ( TBH ) is a provincial hospital with a catchment of 100 000, providing its population with an on‐site ERCP service. Transporting patients to the nearest tertiary centre would incur significant costs to both the patient and district health board . Aims To determine the outcomes of performing ERCP at TBH and compare these with published figures. To determine if it is a safe and effective option for patients in this region. Methods An ambi‐directional study of all ERCP procedures at TBH between January 2011 and December 2015 was conducted. Patient demographics, procedure indication and procedural details were captured via ProVation ? MD and endoscopist's notes. Complications were identified through patient's notes and recorded if occurring within 30 days of the procedure. All complications were graded mild, moderate or severe based on a grading system described by Cotton et al . Results A total of 445 procedures were performed. Bile duct cannulation rate was 92.3% and therapeutic success rate was 89.9%. Complications occurred in 8.99% of patients and ERCP ‐specific mortality was 0.22%. Haemorrhage occurred in 1.35% of patients, pancreatitis in 5.2% and perforation in 0.45%. Success and complication rates are similar to other published studies. Conclusion ERCP can be safely and successfully performed in a provincial centre.
机译:背景技术内窥镜逆行胆管胰岛素(ERCP)是胰腺病理学管理中的必要工具。它在技术上要求苛刻,有可能造成显着的发病率和死亡率。几项试验已经确定了小中心和降低医院体积,因为危险因素较低的成功率和更高的并发症率。 Taranaki基地医院(TBH)是一家省级医院,集水量为100 000,提供其现场ERCP服务的人口。将患者运送到最近的第三级中心将对患者和区卫生局产生重大成本。旨在确定在TBH下表演ERCP的结果,并将这些与已发表的数字进行比较。确定它是否是该地区患者的安全有效的选择。方法对2011年1月至2015年12月间TBH的所有ERCP程序的AMBI定向研究进行了实施。患者人口统计学,程序指示和程序细节通过排列捕获? MD和内窥镜师的笔记。通过患者的票据确定并发症,并在程序后30天内记录。基于Cotton等人描述的分级系统,所有并发症的所有并发症都分级温和,中度或严重。结果总共进行了445个程序。胆管插管率为92.3%,治疗成功率为89.9%。在8.99%的患者中发生并发症,ERCP-特异性死亡率为0.22%。出血发生在1.35%的患者中,胰腺炎的5.2%,穿孔0.45%。成功和并发症率类似于其他公布的研究。结论ERCP可以在省中心安全且成功地进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号